RPG LIFE SCIENCES: SUBSIDIARY TO ACQUIRE API BUSINESS FOR ₹135 CR
• RPG Active Pharma to acquire API & Intermediates business of Raghava Life Sciences for up to ₹135 Cr.
• Acquisition includes a modern ~300 KL API facility near Hyderabad.
• Business has 22 commercialised APIs and 7 APIs under development.
• Deal strengthens RPG’s API portfolio, manufacturing capacity and export opportunities.
• Acquisition to be funded through RPGAP’s recent equity raise.
September 2, 2026 1K
